ZUG, Switzerland--(BUSINESS WIRE)--Galderma will be presenting the latest data from the Sculptra ® (injectable poly-L-lactic acid, PLLA-SCA) Cheek Wrinkle and Alluzience ® (abobotulinumtoxinA solution ...

Sculptra ®, the first proven regenerative biostimulator, has received European Union (EU) Medical Device Regulation (MDR) certification, expanding its current clinical application for the face to ...

-- Galderma celebrates the 25th anniversary of the approval of Sculptra(R), the first proven regenerative biostimulator, with new data, another approval, and expanding treatment applications1-5 -- New ...

Sculptra ®, the first proven regenerative biostimulator, will provide new options for patients in China who are looking for innovative treatments to correct mid-facial volume loss and/or contour ...

(MENAFN- AETOSWire) (business wire )--Galderma will be presenting the latest data from the Sculptra® (injectable poly-L-lactic acid, PLLA-SCA) Cheek Wrinkle and Alluzience® (abobotulinumtoxinA ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the certification of Sculptra for body indications in the European Union (EU) following its certification under the EU ...

In the study, the response rate at month 12 was significantly higher for Sculptra compared to the control group (71.6% vs 26.1%). At months seven to 12, those treated with Sculptra also had improved ...

Galderma will be presenting the latest data from the Sculptra (injectable poly-L-lactic acid, PLLA-SCA) Cheek Wrinkle and Alluzience (abobotulinumtoxinA solution) STAR studies at the 21st Aesthetic ...